Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Oct 04, 2020)
Date Submitted: Dec 19, 2019
Open Peer Review Period: Dec 19, 2019 - Feb 13, 2020
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
An mHealth Intervention to Improve Medication Adherence: A Randomized Controlled Trial
ABSTRACT
Background:
The treatment of many chronic illnesses involves long-term pharmaceutical therapy. Nevertheless, it is an ongoing challenge to find effective ways to change medication adherence to promote good health outcomes. Particularly for patients with coronary heart disease, taking cardio-protective medications can prevent the enlargement of harmful clots, cardiovascular symptoms, and poor therapeutic outcomes such as uncontrolled high blood pressure and hyperlipidemia. Poor adherence to cardio-protective medications, however, has been reported as a global health concern among patients with coronary heart disease and is particularly so in China.
Objective:
To evaluate the efficacy of an mHealth intervention of using two mobile apps on medication adherence score and health outcomes.
Methods:
A randomized, placebo controlled, two-arm parallel study was conducted in a major university-affiliated medical center located in Chengdu, China. Participants were recruited by using flyers and healthcare provider referral. For each participant, the study lasted for 90 days, including a 60-day period of mHealth intervention, and a 30-day period of none-intervention follow-up. Participants in the experimental group received medication-taking reminders and educational materials from the two mobile apps, Message Express and WeChat, respectively. Participants in the control group only received educational materials.
Results:
The mean of the decrease of medication non-adherence score was not statistically significant at either 60 days (t=2.04, df=179, P=.04) or 90 days (t=3.48, df=155, P<.01). Systolic blood pressure and diastolic blood pressure decreased in the experimental group, but increased in the control group. The mean of the decrease in diastolic blood pressure was statistically significant at both 60 days (t=2.07, df=160, P=.04) and 90 days (t=2.21, df=164, P=.03). The mean of the decrease in systolic blood pressure was statistically significant at 90 days (t=3.12, df=165, P<.01), but not significant at 60 days (t=1.92, df=161, P=.06).
Conclusions:
The efficacy of improving medication adherence and health outcomes including systolic blood pressure and diastolic blood pressure by the proposed mHealth intervention is high. Clinical Trial: This study received ethical approval from the Duke Health Institutional Review Board (Pro00073395) on 05/05/2018. The first recruitment was on 05/20/2018. Its pilot study was registered in ClinicalTrials.gov (NCT02793830) on 06/08/2016 and was updated on 01/30/2017.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.